PARLIAMENTARY WRITTEN QUESTION
Brain: Tumours (14 October 2024)
Question Asked
Asked by:
David Simmonds (Conservative)
Answer
Research is crucial in tackling cancer, which is why the Department spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). Cancer is the largest area of spend, at over £121.8 million in 2022/23, and with the NIHR spending more on cancer than any other disease group, reflecting its high priority.
Over the last five years, the NIHR has directly invested £11.3 million on brain tumour research. In addition, our wider investments in NIHR research infrastructure, facilities, services, and the research workforce, allows us to leverage research funding from other donors and organisations. These investments are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total, NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time. These investments are complemented by efforts led by UK Research and Innovation and the Medical Research Council.
Brain cancer remains one of the hardest to treat cancers in both adults and children and we urgently need more research to inform our efforts, which is why the NIHR announced new research funding opportunities for brain cancer research last month, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation. Further information is available at the following link:
https://www.nihr.ac.uk/news/new-funding-opportunities-novel-brain-tumour-research-launched
Brain cancer and children's cancer research will continue to be a priority into the future, and the Department, through the NIHR, will continue to fund high-quality science to expand lifesaving and life-improving research.
Answered by:
Andrew Gwynne (Labour)
23 October 2024
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.